Simplified guideline for prescribing medical cannabinoids in primary care.  Allan GM, Ramji J, Perry D, Ton J, Beahm NP, Crisp N, Dockrill B, Dubin RE, Findlay T, Kirkwood J, Fleming M, Makus K, Zhu X, Korownyk C, Kolber MR, McCormack J, Nic...

EMCDDA operating guidelines for the European Union Early Warning System on new psychoactive substances EMCDDA, Lissabon, 2019 https://www.emcdda.europa.eu/publications/guidelines/operating-guidelines-for-the-european-union-early-warning-system-o...

The Largest Guideline Library in the World! Available online, in mobile app, and via our APIs AI-Driven search to find the right information at the right time https://www.guidelinecentral.com/

Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review.  Russell C, Ashley J, Ali F, Bozinoff N, Corace K, Marsh DC, Mushquash C, Wyman J, Zhang M, Lan...

The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder Developed by ASAM and AAAP, this guideline focuses on the identification, diagnosis, treatment, and promotion of recovery for patients with stimulant use disord...

ASAM and AAAP Announce New Clinical Practice Guideline to Address Rising Stimulant Use Disorders The American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP) have jointly developed a crucial Clinical P...